Version history

{
  "session_id": "sess-hyp-78891e7dfa87",
  "round_number": 1,
  "agent_persona": "persona-theorist",
  "agent_backend": "llm",
  "action": "propose",
  "content": "\n\n# Systematic Evaluation: ACSL4-Driven Ferroptotic Priming in Disease-Associated Oligodendrocytes Underlying White Matter Degeneration in Alzheimer's Disease\n\n## Summary Assessment\n\nThis hypothesis proposes a mechanistically coherent model linking ACSL4-mediated metabolic reprogramming in oligodendrocytes to ferroptotic cell death and white matter degeneration in Alzheimer's disease. The lipid peroxidation framework is well-established in ferroptosis biology, and ACSL4's role as a crucial determinant of ferroptosis sensitivity is supported by substantial evidence. The integration with AD-relevant pathological stressors (iron accumulation, oxidative stress, glutathione depletion) provides biological plausibility. However, key gaps remain in demonstrating causality in human AD tissue and establishing ACSL4 inhibition as a therapeutically tractable intervention for white matter protection.\n\n**Confidence Score: 0.76**\n\n---\n\n## 1. Mechanistic Rationale\n\n### 1.1 ACSL4 Biochemistry and Ferroptosis Execution\n\nThe hypothesis correctly identifies ACSL4's enzymatic function: ATP-dependent esterification of arachidonic acid",
  "tokens_used": "282",
  "persona_id": "persona-theorist"
}